Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 1
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.
Karlsson L, Cheuk D, De Moerloose B, Hasle H, Jahnukainen K, Juul-Dam KL, Kaspers G, Kovalova Z, Lausen B, Nyström UN, Palle J, Pronk CJ, Saks K, Tierens A, Zeller B, Abrahamsson J. Karlsson L, et al. Among authors: juul dam kl. Br J Haematol. 2023 May;201(4):757-765. doi: 10.1111/bjh.18685. Epub 2023 Feb 10. Br J Haematol. 2023. PMID: 36762836
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.
Hammer ASB, Juul-Dam KL, Sandahl JD, Abrahamsson J, Czogala M, Delabesse E, Haltrich I, Jahnukainen K, Kolb EA, Kovács G, Leverger G, Locatelli F, Masetti R, Noren-Nyström U, Raimondi SC, Rasche M, Reinhardt D, Taki T, Tomizawa D, Zeller B, Hasle H, Kjeldsen E. Hammer ASB, et al. Among authors: juul dam kl. Blood Adv. 2023 Mar 28;7(6):1045-1055. doi: 10.1182/bloodadvances.2022008251. Blood Adv. 2023. PMID: 36332007 Free PMC article.
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
Juul-Dam KL, Ommen HB, Nyvold CG, Walter C, Vålerhaugen H, Kairisto V, Abrahamsson J, Alm SJ, Jahnukainen K, Lausen B, Reinhardt D, Zeller B, von Neuhoff N, Fogelstrand L, Hasle H. Juul-Dam KL, et al. Br J Haematol. 2020 Jul;190(2):198-208. doi: 10.1111/bjh.16560. Epub 2020 Mar 16. Br J Haematol. 2020. PMID: 32175599 Free article.
Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol.
Zeller B, Arad-Cohen N, Cheuk D, De Moerloose B, Navarro JMF, Hasle H, Jahnukainen K, Juul-Dam KL, Kaspers G, Kovalova Z, Jonsson OG, Lausen B, Munthe-Kaas M, Nystrom UN, Palle J, Pasauliene R, Pronk CJ, Saks K, Tierens A, Abrahamsson J. Zeller B, et al. Among authors: juul dam kl. Haematologica. 2024 May 9. doi: 10.3324/haematol.2024.285285. Online ahead of print. Haematologica. 2024. PMID: 38721737 Free article.
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.
Tierens A, Arad-Cohen N, Cheuk D, De Moerloose B, Fernandez Navarro JM, Hasle H, Jahnukainen K, Juul-Dam KL, Kaspers G, Kovalova Z, Lausen B, Norén-Nyström U, Palle J, Pasauliene R, Jan Pronk C, Saks K, Zeller B, Abrahamsson J. Tierens A, et al. Among authors: juul dam kl. J Clin Oncol. 2024 Apr 11:JCO2301841. doi: 10.1200/JCO.23.01841. Online ahead of print. J Clin Oncol. 2024. PMID: 38603646